This presentation meets the APA standards for course content and syllabus by including both clinical and empirical support in the contemporary peer reviewed scientific literature. Ketamine and KAP are the sole topics at two annual national conventions: KRIYA and ASKP. The presenters have both presented at previous KRIYA conferences, as well as other national and international conferences on psychedelic-assisted psychotherapy and KAP. In addition, both presenters have co-led intensive training workshops on KAP to help clinicians learn how to approach this work, integrating prior psychotherapy training, philosophies and style with this new medicine and new protocols of treatment.
1.Attendees will be able to describe five main elements of the theory and practice of ketamine assisted (and psychedelic-assisted) psychotherapy.
2.Attendees will be able to name three stages of the ketamine assisted therapy protocol.
3.Attendees will be able to describe two screening interventions to assess suitability of ketamine assisted therapy for patients.
Hyde, S.J. (2015). Ketamine For Depression. Xlibris: Australia.
Jansen, K.L. (2004). Ketamine Dreams and Realities. MAPS: Santa Cruz, CA.
Lattin, D. (2017). Changing Our Minds: Psychedelic sacraments and the new psychotherapy. Synergetic Press: Santa Fe, NM.
Mathew, S.J. & Zarate, Jr., C.A. (Eds.) (2016). Ketamine for Treatment Resistant Depression: The first decade of progress. Springer International: Switzerland.
Pollen, M. (2019). How to Change Your Mind. Penguin Books: New York
Wolfson, P. & Hartelius, G. (Eds.) (2016). The Ketamine Papers. MAPS: Santa Cruz, CA.
Yew, D. (Ed.) (2015). Ketamine Use and Abuse. CRC Press/Taylor and Francis: New York.
Aust, S. et al. (2019). Anxiety during ketamine infusions is associated with negative treatment responses in major depressive disorder. European Neuropsychopharmacology, February, 2019, 1-10.
Dakwar, E. et al. (2019). A single ketamine infusion combined with mindfulness-based behavioral modification to treat cocaine dependence: A randomized clinical trial. American Journal of Psychiatry, 176 (11), 923-931.
Domino, E. F. (2010). Taming the keta678-684.mine tiger. Anesthesiology, 113 (3),
Dore, J. et al. (2019). Ketamine-assisted psychotherapy (KAP): Patient demographics, clinical data, and outcomes in three large practices administering ketamine with psychotherapy. Journal of Psychoactive Drugs, 51 (2), 189-198.
Feifel, D., Malcolm B., Boggie, D., and Lee, K. (2017). Low-dose ketamine for treatment resistant depression in an academic clinical practice setting. Journal of Affective Disorders, 221, 283-288.
Morgan, C.J.A. and Curran, H.V. (2011). Ketamine Use: A review. Addiction, 107, 27-38.
Newcombe, R. (2008). Ketamine Case Study: The phenomenology of a ketamine experience. Addiction Research and Theory, 16 (3), 209-215.
Pahnke, W. N. (1966). Drugs and Mysticism. International Journal of Parapsychology, 8(2), 295-313.
Philips, J. L. et al. (2019). Single, repeated, and maintenance ketamine infusions for treatment resistant depression: A randomized controlled trial. American Journal of Psychiatry, 176 (5), 401-409.
Ross, C., Jain, R., Bonnett, C.J. and Wolfson, P. (2019). High-dose ketamine infusion for the treatment of posttraumatic stress disorder in combat veterans. Annals of Clinical Psychiatry, 31(4), 271-276.
Satoshi, D. et al. (2019). Role of neuronal VEGF signaling in the prefrontal cortex in the rapid antidepressant effects of ketamine. American Journal of Psychiatry, 176 (5), 388-400.
Websites for further information (including additional references and videos)
Polaris Insight Center (SF) www.polarisinsight.com
Kriya Research Institute (Berkeley/East Bay) www.kriyainstitute.com
Sage Integrative Health (Berkeley/East Bay) www.sageintegrativehealth.org
Helios Psychiatry (Woodside/Peninsula) www.heliospsychiatry.com
Ketamine Research Foundation (San Anselmo, Marin) www.ketamineresearchfoundation.com
Healing Realms Center (SF) www.healingrealmscenter.com
CPA is co-sponsoring with SCCPA & SMCPA. The California Psychological Association is approved by the American Psychological Association to sponsor continuing education for psychologists. CPA maintains responsibility for this program and its contents.
Important Notice: Those who attend the workshop and complete the CPA evaluation form will receive 2 continuing education credits. Please note that APA CE rules require that we give credit only to those who attend the entire workshop. Those arriving more than 15 minutes after the start time or leaving before the workshop is completed will not receive CE credits.